1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hypolipoproteinemia

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hypolipoproteinemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chonn, A; Pritchard, PH; Yeung, CC	1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hypolipoproteinemia

Article	Year
The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease). Blood, 1985, Volume: 66, Issue:6 Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Humans; Hypolipoproteinemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Phenotype; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Tangier Disease	1985

Article

Year

The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease).

Blood, 1985, Volume: 66, Issue:6

Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Humans; Hypolipoproteinemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Phenotype; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Tangier Disease

1985